Antidepressant effect of modified SuHeXiang Wan alone and in combination with fl...
연구 요약
Antidepressant effect of modified SuHeXiang Wan alone and in combination with fluoxetine in mice exposed to chronic immobilization stress by activating AMPK/AKT/CREB/BDNF signaling pathway.
Neuroscience 학술지에 발표된 이 연구는 Liu QF, Nguyen LTH, Kim GW 외 연구팀이 수행하였습니다.
이 연구는 'Antidepressant effect of modified SuHeXiang Wan alone and in combination with fluoxetine in mice exposed to chronic immobilization stress by activating AMPK/AKT/CREB/BDNF signaling pathway.'에 대한 과학적 분석을 제공합니다.
핵심 내용
SuHeXiang Wan and its constituents have been traditionally used to treat various central nervous system diseases. Although its neuroprotective effect has been demonstrated, studies on its antidepressant activity and mechanisms of action are limited. This study aimed to examine the antidepressant properties of a modified formulation of SuHeXiang Wan (termed "KSOP1009") as a single treatment or in combination with fluoxetine and to elucidate the underlying mechanisms involved. The neuroprotective and anti-neuroinflammatory effects of KSOP1009 were demonstrated in in vitro models of depression. The antidepressant activities of KSOP1009 or KSOP1009 + fluoxetine were validated using an immobilization stress-induced depression mouse model. KSOP1009 pretreatment (200 mg/kg) significantly alleviated depression-like behaviors, reduced serum CORT, IL-6, and TNF-α levels, as well as restored AMPK/AKT/CREB/BDNF signaling pathway in the brain. Moreover, the combination of fluoxetine and KSOP1009 significantly improved stress-induced depression and anxiety behaviors by downregulating inflammation-related genes, upregulating neural circuit-related genes, and neurogenesis-related proteins. This study confirmed the antidepressant properties of KSOP1009 and demonstrated the synergistic effects of the combination of KSOP1009 and fluoxetine in a mouse model of depression by improving neurogenesis and reducing neuroinflammation, suggesting that KSOP1009 might hold promise as an alternative and integrative treatment for managing depression.
일반인을 위한 해석
구체적인 실천 사항은 담당 의사 또는 약사와 상담하시기 바랍니다.
실천 사항
- 현재 복용 중인 약물이나 영양제에 대해 궁금한 점이 있다면 담당 의사 또는 약사와 상담하시기 바랍니다
- 약물이나 영양제의 용법·용량을 임의로 변경하지 마세요
- 이상 반응이 나타나면 즉시 전문가에게 문의하세요
의사/약사의 전문적 판단을 대체하지 않습니다 (PMID: 41290069)
이 연구와 관련된 약물을 복용 중인가요?
상호작용 체크하러 가기이 정보는 의학 논문의 요약이며, 의사/약사의 전문적 판단을 대체하지 않습니다.